Malmö, Sweden

Lars A Carlsson

This inventor holds 1 USPTO granted patent. Top assignee: Ferring Ab. Active years: 1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars A Carlsson. Retrieved from https://idiyas.com/inventor/lars-a-carlsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1979

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lars A. Carlsson

Introduction

Lars A. Carlsson is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides with antidiuretic properties. His work has implications for various medical applications, showcasing the importance of innovation in healthcare.

Latest Patents

Lars A. Carlsson holds a patent for an "Antidiuretically effective polypeptide and a process for preparing the antidiuretically effective vasopressin derivatives." This patent outlines a method for producing specific amino acid sequences that can be utilized in therapeutic settings. The patent is a testament to his expertise and dedication to advancing medical science.

Career Highlights

Throughout his career, Lars has been associated with Ferring Ab, a company known for its focus on developing innovative pharmaceuticals. His work at Ferring Ab has allowed him to contribute to groundbreaking research and development in the field of biochemistry.

Collaborations

Lars A. Carlsson has collaborated with Jan L. Mulder, who is now deceased. Their partnership highlights the collaborative nature of scientific research, where ideas and expertise are shared to foster innovation.

Conclusion

Lars A. Carlsson's contributions to the field of biochemistry through his patent and work at Ferring Ab exemplify the impact of innovation in medicine. His dedication to research continues to inspire future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…